FREE TRIAL - NO CARD NEEDED
Pubrio gives your team the data, timing, and tools to reach the right prospects before the competition does.
Company & people search
Filter 560M+ contacts by role, industry, tech stack & more.
Sequences
Automate multi-step outreach without losing the personal touch.
Market signals
Stay ahead of every market shift. Pubrio Signals watches companies for you and delivers the right intelligence.
Start your free trial
Join 9,000+ revenue teams already using Pubrio.
No credit card · Cancel anytime · GDPR safe
Already have an account?Log in

LambdaVision, Inc.
United States · Biotechnology
Biotechnology
Healthcare
Aerospace
LambdaVision, Inc. is a biotechnology company dedicated to developing a photoactive, protein-based artificial retina aimed at restoring vision for patients affected by advanced retinal degenerative diseases, such as retinitis pigmentosa and age-related macular degeneration. Founded in 2009 as a spinoff from the University of Connecticut, LambdaVision addresses the critical need for effective treatments that can restore meaningful sight rather than just slowing disease progression. The company's innovative implant utilizes bacteriorhodopsin, a light-activated protein that mimics the function of human photoreceptors. This small and flexible device allows for a simpler surgical procedure, enhancing its appeal to retinal surgeons. LambdaVision is also pioneering microgravity manufacturing techniques in collaboration with NASA and Space Tango, which aim to improve the production quality of its retinal implant. The company is focused on preclinical development and regulatory consulting to prepare for clinical trials, initially targeting patients with retinitis pigmentosa.
2009
Founded
Biotechnology
Industry
United States
Location
45,117,022
Ranking
10 employees
Size

Get full access to view complete information

© 2026 Pubrio. All rights reserved.